Briggs Morrison

Briggs Morrison is a medical oncologist turned biopharma leader who runs Crossbow Therapeutics, a Cambridge, Massachusetts company building TCR-mimetic antibody drugs that aim T-cells at cancer targets once thought unreachable. Before Crossbow he ran late-stage R&D at the scale of an industry giant, serving as Chief Medical Officer and EVP of Global Medicines Development at AstraZeneca, and holding senior development roles at Pfizer and Merck across three decades. His fingerprints are on blockbuster cancer medicines including TAGRISSO and LYNPARZA. Today he splits his identity between operator and investor: CEO of Crossbow, Entrepreneur Partner at MPM BioImpact, and a fixture on biotech boards including chair of Arvinas.